Sphera Funds Management Ltd. Mersana Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.08 - $9.55 $1.26 Million - $3.9 Million	407,941 Added 3840.89%	418,562 $1.38 Million
Q1 2023 May 15, 2023	BUY	$4.0 - $7.02 $42,484 - $74,559	10,621 New	10,621 $43,000
Q4 2019 Feb 13, 2020	SELL	$1.45 - $6.73 $290,000 - $1.35 Million	-200,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.51 - $7.3 $702,000 - $1.46 Million	200,000 New	200,000 $1.05 Million

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.